August 1, 2024

How Research & Education Can Impact an Aging Society: A Singapore Perspective

“We’re in the age of precision medicine. I think we need to move into precision health promotion, precision medical education to provide very targeted, very personalized medical advice for each individual, and to be able to better measure the outcomes at the individual level.” – Benjamin Seet

“A Dialogue on Healthy Aging” features a video interview with Dr. Benjamin Seet, Group Chairman Medical Board (Research), National Healthcare Group in Singapore by Dr. Hui Cai, VP and Head of Content, WuXi AppTec.

EVENTS

WuXi Executive Breakfast in Basel: The Most Important Innovation in Drug R&D May Be How the Industry Works Together

Reflections from the WuXi Executive Breakfast at Swiss Biotech Day

May 11, 2026

READ MORE

FEATURED

Reflection on the First Approved PROTAC and the Future of Small Molecule Drugs: A Conversation with Prof. Craig Crews, Yale University

In May 2026, the FDA approved the first PROTAC therapy, marking the arrival of an entirely new class of medicines built on a once-radical idea: instead of merely inhibiting disease-causing proteins, drugs could be designed to eliminate them altogether. At the center of that story is Prof. Craig Crews, whose laboratory at Yale University helped pioneer the PROTAC (PROteolysis TArgeting Chimera) approach more than two decades ago.

June 8, 2026

Many years later, staring at five kilograms of pale drug powder sealed inside a plastic bag, Craig Crews remembered that afternoon in the late 1990s, when almost nobody stopped to see his poster.

June 8, 2026

We spoke with Dr. Weninger to understand her strategy for building the next generation of neuroscience companies and her vision for ushering in a new era of therapies for devastating brain disorders.

October 30, 2025

READ MORE